JP2012521745A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012521745A5 JP2012521745A5 JP2012501093A JP2012501093A JP2012521745A5 JP 2012521745 A5 JP2012521745 A5 JP 2012521745A5 JP 2012501093 A JP2012501093 A JP 2012501093A JP 2012501093 A JP2012501093 A JP 2012501093A JP 2012521745 A5 JP2012521745 A5 JP 2012521745A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- mitochondrial fusion
- mammal
- acid sequence
- isolated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010028980 Neoplasm Diseases 0.000 claims 10
- 201000011510 cancer Diseases 0.000 claims 10
- 230000002438 mitochondrial effect Effects 0.000 claims 10
- 230000004927 fusion Effects 0.000 claims 7
- 241000124008 Mammalia Species 0.000 claims 6
- 108020001507 fusion proteins Proteins 0.000 claims 5
- 102000037865 fusion proteins Human genes 0.000 claims 5
- 239000000523 sample Substances 0.000 claims 5
- 108020005196 Mitochondrial DNA Proteins 0.000 claims 4
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 4
- 239000000427 antigen Substances 0.000 claims 4
- 108091007433 antigens Proteins 0.000 claims 4
- 102000036639 antigens Human genes 0.000 claims 4
- 238000003556 assay Methods 0.000 claims 4
- 239000012634 fragment Substances 0.000 claims 4
- 150000007523 nucleic acids Chemical group 0.000 claims 4
- 230000000295 complement effect Effects 0.000 claims 3
- 238000009396 hybridization Methods 0.000 claims 3
- 206010006187 Breast cancer Diseases 0.000 claims 2
- 208000026310 Breast neoplasm Diseases 0.000 claims 2
- 206010009944 Colon cancer Diseases 0.000 claims 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 2
- 206010033128 Ovarian cancer Diseases 0.000 claims 2
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 2
- 206010060862 Prostate cancer Diseases 0.000 claims 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 2
- 208000024313 Testicular Neoplasms Diseases 0.000 claims 2
- 206010057644 Testis cancer Diseases 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 208000030381 cutaneous melanoma Diseases 0.000 claims 2
- 201000005202 lung cancer Diseases 0.000 claims 2
- 208000020816 lung neoplasm Diseases 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 201000001441 melanoma Diseases 0.000 claims 2
- 201000003120 testicular cancer Diseases 0.000 claims 2
- 210000001519 tissue Anatomy 0.000 claims 2
- 238000010324 immunological assay Methods 0.000 claims 1
- 230000035772 mutation Effects 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CAPCT/CA2009/000351 | 2009-03-27 | ||
| PCT/CA2009/000351 WO2009117811A1 (en) | 2008-03-28 | 2009-03-27 | Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor |
| PCT/CA2010/000423 WO2010115261A1 (en) | 2009-03-27 | 2010-03-29 | Aberrant mitochondrial dna, associated fusion transcripts and translation products and hybridization probes therefor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012521745A JP2012521745A (ja) | 2012-09-20 |
| JP2012521745A5 true JP2012521745A5 (cg-RX-API-DMAC7.html) | 2013-05-16 |
| JP5734947B2 JP5734947B2 (ja) | 2015-06-17 |
Family
ID=42937093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012501093A Expired - Fee Related JP5734947B2 (ja) | 2009-03-27 | 2010-03-29 | 異常型ミトコンドリアｄｎａ、関連融合転写物および翻訳産物、並びにそのハイブリダイゼーションプローブ |
Country Status (6)
| Country | Link |
|---|---|
| EP (2) | EP3272871B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5734947B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101720555B1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2010234238B2 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2011137486A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010115261A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2719718C (en) | 2008-03-28 | 2019-07-02 | Mitomics, Inc. | Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor |
| TWI709188B (zh) | 2018-09-27 | 2020-11-01 | 財團法人工業技術研究院 | 基於機率融合的分類器、分類方法及分類系統 |
| CN113025633B (zh) * | 2019-12-09 | 2024-08-27 | 武汉纽福斯生物科技有限公司 | 编码人nadh脱氢酶亚单位1蛋白的核酸及其应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| US5807522A (en) | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
| US6218117B1 (en) * | 1998-06-15 | 2001-04-17 | Mitokor | Compositions and methods for identifying agents that quantitatively alter detectable extramitochondrial DNA:mitochondrial DNA ratios |
| WO2002101086A2 (en) * | 2001-06-11 | 2002-12-19 | 1304854 Ontario Ltd. | Complete mitochondrial genome sequences as a diagnostic tool for the health sciences |
| US20030162174A1 (en) * | 2001-06-11 | 2003-08-28 | Sutherland John W. | Detecting nucleic acid deletion sequences |
| DK1877559T3 (da) * | 2005-04-18 | 2011-02-07 | Mitomics Inc | Mitochondrial mutationer og omarrangeringer som et diagnostisk værktøj for detektion af soleksponering, prostatacancer og andre cancertyper |
| NZ584815A (en) | 2007-09-26 | 2012-07-27 | Mitomics Inc | 3.4 kb mitochondrial dna deletion for use in the detection of cancer |
| CA2719718C (en) * | 2008-03-28 | 2019-07-02 | Mitomics, Inc. | Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor |
-
2010
- 2010-03-29 EP EP17188792.0A patent/EP3272871B1/en active Active
- 2010-03-29 AU AU2010234238A patent/AU2010234238B2/en not_active Ceased
- 2010-03-29 RU RU2011137486/10A patent/RU2011137486A/ru not_active Application Discontinuation
- 2010-03-29 WO PCT/CA2010/000423 patent/WO2010115261A1/en not_active Ceased
- 2010-03-29 JP JP2012501093A patent/JP5734947B2/ja not_active Expired - Fee Related
- 2010-03-29 EP EP10761136.0A patent/EP2411522B1/en not_active Not-in-force
- 2010-03-29 KR KR1020117025261A patent/KR101720555B1/ko not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015533788A5 (cg-RX-API-DMAC7.html) | ||
| US10705089B2 (en) | Methods and kits for the diagnosis of cancer | |
| JP6715770B2 (ja) | モノクローナル抗ｔｋ１抗体 | |
| RU2014108048A (ru) | Способ обнаружения рака поджелудочной железы | |
| JP2018042573A5 (cg-RX-API-DMAC7.html) | ||
| JO3812B1 (ar) | أجسام مضادة ترتبط بالمركب الترابطي البشري للموت المبرمج 1 (pd-l1) | |
| JP2014239695A5 (cg-RX-API-DMAC7.html) | ||
| BR112018070823A2 (pt) | anticorpo sirpa anti-humano ou fragmento de ligação a antígeno do mesmo ou mimético de anticorpo de ligação a antígeno, composição farmacêutica, produto de combinação, molécula de ácido nucleico isolada, vetor, célula hospedeira isolada, polipeptídeo, métodos para fabricar um anticorpo, in vitro ou ex vivo para determinar células positivas para sirpa, de diagnóstico e para prever a resposta de um sujeito, e, uso de um anticorpo anti-sirpa ou um fragmento de ligação a antígeno do mesmo ou um mimético de ligação a anticorpo e in vitro ou ex vivo de pelo menos um anticorpo sirpa anti-humano ou fragmento de ligação a antígeno do mesmo ou mimético de anticorpo de ligação a antígeno. | |
| JP2009001563A5 (cg-RX-API-DMAC7.html) | ||
| JP2011512817A5 (cg-RX-API-DMAC7.html) | ||
| BR112012007365A2 (pt) | proteínas de ligação à il-1 | |
| NZ603492A (en) | Humanized anti-factor d antibodies and uses thereof | |
| ATE474857T1 (de) | Antikörper gegen ein epitop auf agr2, assays und hybridome | |
| JP6815331B2 (ja) | 前立腺がんの分析のための組成物及び方法 | |
| JP2009539082A5 (cg-RX-API-DMAC7.html) | ||
| JP2017505436A5 (cg-RX-API-DMAC7.html) | ||
| JP2012501318A5 (cg-RX-API-DMAC7.html) | ||
| JP2016536568A5 (cg-RX-API-DMAC7.html) | ||
| WO2010045495A3 (en) | Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof | |
| ES2545515T3 (es) | Biomarcadores combinatorios para aplicaciones clínicas en la gestión del paciente con cáncer de pulmón | |
| MX353464B (es) | Antigenos tpn47 de treponema pallidum, inmunoreactivos, solubles. | |
| JP2014518624A5 (cg-RX-API-DMAC7.html) | ||
| RU2022108606A (ru) | Антитела к фактору ix padua | |
| WO2008054724A3 (en) | Monoclonal antibodies against osteopontin | |
| JP2012521745A5 (cg-RX-API-DMAC7.html) |